Preview

Rational Pharmacotherapy in Cardiology

Advanced search

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS

https://doi.org/10.20996/1819-6446-2015-11-4-365-370

Full Text:

Abstract

Aim. To study the changes of plasma levels of NT-proBNP and NT-proANP in patients with persistent atrial fibrillation (AF) treated with various antiarrhythmic drugs.

Material and methods. Patients with persistent AF (n=123) aged 39-83 years old were included into the study. The patients were divided into 2 groups: group 1 included patients with arterial hypertension (n=61), group 2 - patients with ischemic heart disease (IHD; n=62). After sinus rhythm restoration the patients were divided into 4 subgroups. Patients of 1A subgroup used propafenone to maintain sinus rhythm during the next 6 months, while patients of 2A subgroup used amiodarone. Patients of 1B and 2B subgroups used bisoprolol to control ventricular rate. Plasma natriuretic peptide levels were evaluated in all patients during the first 3 days after the sinus rhythm restoration and 6 months after.

Results. Increased levels of NT-proBNP and NT-proANP in the first days after the sinus rhythm restoration were found in patients of both groups and were associated with the episode of AF. After 6 months of treatment the reduction of NT-proBNP and NT-proANP levels was found in patients of 1A subgroup (NT-proBNP: from 160.5±15.2 pg/ml to 130.1±12.2 pg/ml; NT-proANP: from 15.3±6.4 nmol/L to 11.5±5.3 nmol/L, p<0.05 for both) and of 2A subgroup (NT-proBNP: from 180.2±12.7 to 120.6±10.9 pg/ml; NT-proANP: from 17.1±7.1 to 11.8±7.2 nmol/L, p<0.05 for both). NT-proBNP and NT-proANP levels were decreasing consistently both in hypertensive patients receiving propafenone and in IHD patients taking amiodarone. No significant changes in NT-proBNP and NT-proANP levels were found in patient of subgroups 1B and 2B during the follow-up.

Conclusion. Increased plasma levels of NT-proBNP and NT-proANP were found in the first days after the restoration of sinus rhythm in patients with persistent AF, and after 6 months of sinus rhythm maintenance these levels reduced significantly.

About the Authors

V. I. Podzolkov
I.M. Sechenov First Moscow State Medical University
Russian Federation
Trubetskaya ul. 8-2, Moscow, 119991, Russia


A. I. Tarzimanova
I.M. Sechenov First Moscow State Medical University
Russian Federation
Trubetskaya ul. 8-2, Moscow, 119991, Russia


I. Z. Loriya
I.M. Sechenov First Moscow State Medical University
Russian Federation
Trubetskaya ul. 8-2, Moscow, 119991, Russia


References

1. Camm A.J. Atrial fibrillation and risk. Clin Cardiol 2012; 35 Suppl 1: 1-2.

2. Nishikimi T. Do plasma levels of brain natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) increase in diastolic dysfunction as well as in systolic dysfunction? Circ J 2012;76(11):2540-1.

3. Wei G., Yaqi R., Ningfu W., et al. N-terminal prohormone B-type natriuretic peptide and cardiovascular risk in stable coronary artery disease: a meta-analysis of nine prospective studies. Rev Cardiovasc Med 2013;14(2-4):e92-8.

4. Van der Zee P.M., Verberne HJ, et al. Relation of N-terminal pro B-type natriuretic peptide levels after symptom-limited exercise to baseline and ischemia levels. Am J Cardiol 2009;103(5):604-10.

5. Aldhoon B., Melenovský V., Peichl P., et al. New insights into mechanisms of atrial fibrillation. Physiol Res 2010;59(1):1-12.

6. Cai G.L., Chen J., Hu C.B., et al. Value of plasma brain natriuretic peptide levels for predicting postoperative atrial fibrillation: a systemic review and meta-analysis. World J Surg 2014;38(1):51-9.

7. Wozakowska-Kapłon B., Opolski G., Janion M., et al. Plasma concentration of atrial natriuretic peptide is related to the duration of atrial fibrillation in patients with advanced heart failure. Kardiol Pol 2004;61(12):513-21.

8. Wozakowska-Kaplon B. Changes in plasma natriuretic peptide levels in patients with atrial fibrillation after cardioversion. Int J Cardioln 2010;144(3):436-7.

9. Kurosaki K., Tada H., Hashimoto T. Plasma natriuretic peptide concentrations as a predictor for successful catheter ablation in patients with drug-refractory atrial fibrillation. Circ J 2007; 71: 313-20.

10. Khand A.U., Chew P.G., Douglas H., et al. The effect of carvedilol on B-type natriuretic Peptide and cardiac function in patients with heart failure and persistent atrial fibrillation. Cardiology 2015;130(3):153-8.


For citation:


Podzolkov V.I., Tarzimanova A.I., Loriya I.Z. CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS. Rational Pharmacotherapy in Cardiology. 2015;11(4):365-370. (In Russ.) https://doi.org/10.20996/1819-6446-2015-11-4-365-370

Views: 433


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)